Cell Therapy Raw Materials Market Insights 2025-2034: Growth Forecast and Strategic Priorities

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Cell Therapy Raw Materials Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, there has been significant growth in the size of the cell therapy raw materials market. The market, which was valued at $4.20 billion in 2024, is projected to reach $5.07 billion in 2025, growing at a compound annual growth rate (CAGR) of 20.6%. This uptick throughout the past period can be linked to the expansion of contract development and manufacturing organizations, the rising incidence of autoimmune and genetic diseases, increased government and private financing, heightened emphasis on scalable manufacturing procedures, and a surge in clinical trials.

Cell Therapy Raw Materials Market Size Forecast: What's the Projected Valuation by 2029?
The market size for raw materials used in cell therapy is anticipated to undergo rapid expansion in the coming years, reaching $10.61 billion by 2029, with an expected CAGR of 20.3%. This significant rise during the projected period is likely due to increased demand for regenerative medicine, surging uptake of customised treatments, substantial investment in cell and gene therapy R&D, ascending approvals for cell-based treatments, and escalating cognisance of advanced therapy medicinal products. The forecast period is also expected to witness key growing trends such as improvement in cell culture technology, the amalgamation of automation in bioprocessing, advancements in xeno-free and chemically defined media, progress in cryopreservation technologies, and the implementation of closed-system bioreactors.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cell-therapy-raw-materials-global-market-report

What Are the Drivers Transforming the Cell Therapy Raw Materials Market?
The escalation in the adoption of regenerative medicine is predicted to accelerate the expansion of the cell therapy raw materials market. This branch of medicine focusses on restoring or establishing standard function by regenerating, replacing, or engineering human tissues, cells, or organs. The increasing prevalence of chronic and degenerative diseases, prompting a surge in demand for therapies that restore or substitute damaged tissues rather than solely managing symptoms, contributes to the growth of regenerative medicine. Cell therapy raw materials expedite the advancement of regenerative medicine by supplying the necessary components like growth factors, cell culture media, enzymes, and scaffolds, required for growing, expanding, and preserving therapeutic cells that are utilized to repair or regenerate damaged tissues and organs. For example, in January 2025, the US-based National Library of Medicine reported the approval of 32 new gene therapies, which included genetically modified cell therapies, in 2024. Consequently, the escalating utilization of regenerative medicine is steers the expansion of the cell therapy raw materials market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27245&type=smp

Which Emerging Trends Are Transforming the Cell Therapy Raw Materials Market in 2025?
Leading firms in the cell therapy raw materials market are concentrating on creating inventive solutions like good manufacturing practice (GMP)-compliant manufacturing to ensure safety, uniformity, and regulatory adherence in the entire cell therapy production process. Good manufacturing practice (GMP)-compliant manufacturing is a framework that guarantees the consistent production and regulation of products, as per quality standards defined by regulatory agencies to reduce risks associated with pharmaceutical and biotechnological production. For example, Thermo Fisher Scientific Inc., an American life science and clinical research company, inaugurated a US advanced therapies collaboration center (ATxCC) in April 2025, aiming to promote the creation and commercialization of cell and gene therapies. The ATxCC expedites cell therapy development by offering comprehensive cGMP manufacturing support, cutting-edge technologies, and expert process optimization. It encourages teamwork to overcome manufacturing obstacles and hasten commercialization.

Which Segments in the Cell Therapy Raw Materials Market Offer the Most Profit Potential?
The cell therapy raw materials market covered in this report is segmented

1) By Type: Stem Cell Based Raw Materials, Gene Therapy Raw Materials, CAR-T Cell Therapy Raw Materials
2) By Product Type: Media, Sera, Cell Culture Supplements, Antibodies, Reagents And Buffers, Other Product Types
3) By End User: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organization And Contract Manufacturing Organization, Other End Users

Subsegments:
1) By Stem Cell Based Raw Materials: Growth Factors, Cytokines, Cell Culture Media
2) By Gene Therapy Raw Materials: Transfection Reagents, Nucleotides And Enzymes, Cell Culture Media For Gene Modification
3) By Car-T Cell Therapy Raw Materials: T Cell Activation Reagents, Cell Expansion Media, Cryopreservation Agents

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27245&type=smp

Which Firms Dominate the Cell Therapy Raw Materials Market by Market Share and Revenue in 2025?
Major companies operating in the cell therapy raw materials market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, Corning Incorporated, Lonza Group AG, Grifols SA, Wuxi AppTec Co. Ltd., Charles River Laboratories International Inc., Sartorius Stedim Biotech SA, Bio-Techne Corporation, Stemcell Technologies Inc., Miltenyi Biotec GmbH, Actylis, ACROBiosystems Co Ltd., BioIVT LLC, FUJIFILM Cellular Dynamics, CellGenix GmbH, Promocell GmbH, RoosterBio Inc., and Akron Biotech LLC.

Which Regions Offer the Highest Growth Potential in the Cell Therapy Raw Materials Market?
North America was the largest region in the cell therapy raw materials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27245

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email:saumyas@tbrc.info
The Business Research Company -www.thebusinessresearchcompany.com
Follow Us On:
LinkedIn:https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.